Freeline Therapeutics Companies
Freeline Therapeutics is a biopharmaceutical company that develops liver directed gene therapies for bleeding disorders and other diseases. Its therapies are based on next-generation proprietary AAV vector platform, with its lead program being a gene therapy to treat haemophilia B.
Freeline Therapeutics was founded in 2015 and is headquartered in London, England.
Number Of Exists:
Series C
Industry:
Healthcare Innovations
Headquarters:
Stevenage, Herefordshire, United Kingdom
Technology:
Advanced and Next Generation Therapies (Various)
Employee Number:
11-50